Literature DB >> 29204049

Commentary.

Amauri Dalla-Corte1.   

Abstract

Entities:  

Year:  2017        PMID: 29204049      PMCID: PMC5709912          DOI: 10.4103/jnrp.jnrp_432_17

Source DB:  PubMed          Journal:  J Neurosci Rural Pract        ISSN: 0976-3155


× No keyword cloud information.
The report describes a patient with hypertensive hydrocephalus caused by the H2N3 virus, which is an extremely rare condition.[1] Identification of influenza virus type A in cerebrospinal fluid using polymerase chain reaction method confirmed central nervous system (CNS) involvement. Cerebrospinal fluid biochemistry excluded the presence of meningitis or encephalitis. There was also no associated aqueduct stenosis. The surgically treated coincidental vestibular schwannoma has not been shown to be associated with the hydrocephalus or the neurological symptoms described. Several pathological observations of viral infections of the CNS resulting in hydrocephalus, such as perivascular inflammatory response, subependymal gliosis and neovascularization, necrosis of ependymal cells and aqueductal stenosis have been described in experimental animals. These findings were associated with viral replication.[2] Viruses that have been reported to produce hydrocephalus include parainfluenza type 1[2] and 2,[3] mumps,[4] influenza A,[5] type 12 adenovirus,[6] reovirus type 1,[7] and polyomavirus.[8] Mims have analyzed the intracerebral toxicity for mice of standard and neuroadapted strains of influenza A virus. He described the destruction of the ependymal lining of the ventricles, and a severe inflammatory response originating in the ventricles, but also affecting the ependymal cells covering the choroid plexuses, which eventually produces the frankly hydrocephalic condition seen in mice dying after 6–7 days.[5] Subsequent to the animal studies a number of children have been reported with hydrocephalus and aqueductal stenosis 5 weeks to 4 years after mumps virus infection.[9] Although this report is only the second case described of H3N2 type A influenza virus-related hydrocephalus, clinicians should be aware that influenza virus is a potential cause of brain damage and hydrocephalus. Neuroimaging should be performed early in the presence of signs and symptoms of intracranial hypertension.
  9 in total

1.  Oncogenic effects in hamsters of human adenovirus types 12 and 18.

Authors:  R J HUEBNER; W P ROWE; W T LANE
Journal:  Proc Natl Acad Sci U S A       Date:  1962-12-15       Impact factor: 11.205

2.  An analysis of the toxicity for mice of influenza virus. I. Intracerebral toxicity.

Authors:  C A MIMS
Journal:  Br J Exp Pathol       Date:  1960-12

Review 3.  Hydrocephalus and viral infections.

Authors:  R T Johnson
Journal:  Dev Med Child Neurol       Date:  1975-12       Impact factor: 5.449

4.  Hydrocephalus produced by the 6/94 virus; A parainfluenza type 1 isolate from multiple sclerosis brain tissue.

Authors:  H M Friedman; D H Gilden; F S Lief; L B Rorke; D Santoli; H Koprowski
Journal:  Arch Neurol       Date:  1975-06

5.  Hydrocephalus in hamsters, ferrets, rats, and mice following inoculations with reovirus type I. II. Pathologic studies.

Authors:  G Margolis; L Kilham
Journal:  Lab Invest       Date:  1969-09       Impact factor: 5.662

6.  Hydrocephalus as a sequela of experimental myxovirus infections.

Authors:  R T Johnson; K P Johnson
Journal:  Exp Mol Pathol       Date:  1969-02       Impact factor: 3.362

7.  Hydrocephalus in mice infected with polyoma virus.

Authors:  A Holtz; G Borman; C P Li
Journal:  Proc Soc Exp Biol Med       Date:  1966-04

8.  Hydrocephalus following viral infection: the pathology of aqueductal stenosis developing after experimental mumps virus infection.

Authors:  R T Johnson; K P Johnson
Journal:  J Neuropathol Exp Neurol       Date:  1968-10       Impact factor: 3.685

9.  Hydrocephalus Caused by H3N2 Type A Influenza Virus or Cerebellopontine Angle Schwannoma?

Authors:  Jakob Nemir; Ivan Domazet; Klara Brgic; Natasa Kovac; Goran Mrak
Journal:  J Neurosci Rural Pract       Date:  2017 Oct-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.